The Order of Exposure to Cytotoxic Chemotherapy and the Proteasome Inhibitor Bortezomib Dictates the Extent of Reversal of Chemotherapy Resistance in T-ALL.

Blood

May Y. Szeto, Justin Wahlstrom, Michelle L. Hermiston. The Order of Exposure to Cytotoxic Chemotherapy and the Proteasome Inhibitor Bortezomib Dictates the Extent of Reversal of Chemotherapy Resistance in T-ALL. Blood. 2012 Nov 16; 120(21):1355-1355.

2012
https://researcherprofiles.org/profile/79296796

May Y. Szeto, Justin Wahlstrom, Michelle L. Hermiston